Alzamend Neuro (ALZN)
NASDAQ:ALZN
Holding ALZN?
Track your performance easily

Alzamend Neuro (ALZN) Income Statement

264 Followers

Alzamend Neuro Income Statement

Last quarter (Q ), Alzamend Neuro's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Alzamend Neuro's net income was $-974.41K. See Alzamend Neuro’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Apr 24Apr 23Apr 22Apr 21Apr 20
Total Revenue
-----$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 7.37M$ 9.94M$ 14.87M$ 12.32M$ 4.95M$ 4.42M
Operating Income
$ -7.37M$ -9.94M$ -14.87M$ -12.32M$ -4.95M$ -4.42M
Net Non Operating Interest Income Expense
$ -20.27K$ -10.10K$ -7.70K$ -46.52K$ -157.10K$ 13.93K
Other Income Expense
---$ 4.00K$ -62.42K-
Pretax Income
$ -7.39M$ -9.95M$ -14.88M$ -12.36M$ -5.05M$ -4.41M
Tax Provision
---$ -12.36M$ -5.05M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -7.39M$ -9.95M$ -14.88M$ -12.36M$ -5.05M$ -4.41M
Basic EPS
$ -3.19$ -14.70$ -22.50-$ -1.05$ -0.05
Diluted EPS
$ -3.19$ -14.70$ -22.50-$ -1.05$ -0.05
Basic Average Shares
$ 15.08M$ 676.57K$ 650.13K$ 5.94M$ 4.84M$ 88.75M
Diluted Average Shares
$ 15.08M$ 676.57K$ 650.13K$ 5.94M$ 4.84M$ 88.75M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 7.37M$ 9.94M$ 14.87M$ 12.32M$ 4.95M$ 4.42M
Net Income From Continuing And Discontinued Operation
$ -7.39M$ -9.95M$ -14.88M$ -12.36M$ -5.05M$ -4.41M
Normalized Income
$ -7.32M$ -9.85M-$ -24.72M$ -10.09M$ -4.41M
Interest Expense
-----$ 0.00
EBIT
$ -7.37M$ -9.94M$ -14.87M$ -12.32M$ -4.89M$ -4.41M
EBITDA
$ -7.31M$ -9.89M$ -14.85M$ -12.31M$ -4.77M$ -4.41M
Currency in USD

Alzamend Neuro Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis